ACST 1.29 is valued at $10-15/share. -- Acasti recently pulled the trigger on a public raise for $23 million for 18.4 million units. Each unit consisted of one share and one warrant with an exercise price of $1.50. This allows Acasti to raise an addition $27.6 million in the future, resulting in potentially $50.6 million in cash to drive continued development in prescription-strength krill oil.
If Acasti is able to execute on its strategy for CaPre by attaining FDA approval, valuation should be able to rival Amarin's prior to its FDA advisory panel blow up, in the range of $800-1.2 billion by 2016.
Correspondingly resulting in Acasti being valued at $10-15/share.
Note 1: Please alert the board of any stock crossing the 20,50,20dma’s on daily or weekly chart.
(link back for more charts) Note 2: Please do an 8x34 chart on the stock; the 8x34 cross is the initial reversal sign of most stocks. Use the link below, just replace the ticker symbol. Post on the board when a stock crosses the 8DMA or the 34DMA and when the 8x34 cross is about to occur.
8x34 cross in the making, look at Full Sto, and CMF indicators. just replace the ticker with your TICKER